Back to top
more

Zimmer Biomet (ZBH)

(Delayed Data from NYSE)

$119.35 USD

119.35
1,099,195

-0.40 (-0.33%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $119.32 -0.03 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ZBH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Zimmer Biomet Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 416 376 479 802 618
Receivables 1,442 1,382 1,405 1,453 1,364
Notes Receivable 0 0 0 0 0
Inventories 2,385 2,147 2,395 2,451 2,385
Other Current Assets 366 523 607 378 357
Total Current Assets 4,610 4,427 4,885 5,083 4,724
Net Property & Equipment 2,060 1,873 2,017 2,048 2,077
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 13,675 13,644 15,492 16,317 16,857
Deposits & Other Assets 1,152 1,122 1,063 969 980
Total Assets 21,497 21,066 23,456 24,418 24,639
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 411 354 351 330 401
Current Portion Long-Term Debt 900 544 1,605 500 1,500
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 61 39 65 60 127
Other Current Liabilities 1,486 1,421 1,447 1,667 1,414
Total Current Liabilities 2,857 2,358 3,468 2,557 3,442
Mortgages 0 0 0 0 0
Deferred Taxes/Income 358 475 666 790 840
Convertible Debt 0 0 0 0 0
Long-Term Debt 4,868 5,152 5,464 7,627 6,721
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 926 1,054 1,193 1,245 1,243
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 9,009 9,039 10,790 12,218 12,246
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 3 3
Capital Surplus 9,846 9,504 9,315 9,122 8,920
Retained Earnings 10,385 9,559 10,292 10,087 10,427
Other Equity -183 -173 -226 -293 -237
Treasury Stock 7,562 6,867 6,718 6,720 6,721
Total Shareholder's Equity 12,488 12,027 12,666 12,199 12,393
Total Liabilities & Shareholder's Equity 21,497 21,066 23,456 24,418 24,639
Total Common Equity 12,488 12,027 12,666 12,199 12,393
Shares Outstanding 208.90 209.80 208.90 207.20 205.60
Book Value Per Share 59.78 57.33 60.63 58.88 60.28

Fiscal Year End for Zimmer Biomet Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 416 292 320 330
Receivables NA 1,442 1,341 1,367 1,381
Notes Receivable NA 0 0 0 0
Inventories NA 2,385 2,323 2,276 2,241
Other Current Assets NA 366 416 425 460
Total Current Assets NA 4,610 4,372 4,388 4,412
Net Property & Equipment NA 2,060 2,032 1,975 1,906
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 13,675 13,602 13,771 13,807
Deposits & Other Assets NA 1,152 1,211 1,160 1,119
Total Assets NA 21,497 21,217 21,294 21,244
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 411 320 355 397
Current Portion Long-Term Debt NA 900 355 520 585
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 234
Income Taxes Payable NA 61 97 82 47
Other Current Liabilities NA 1,486 1,300 1,278 1,073
Total Current Liabilities NA 2,857 2,072 2,234 2,336
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 358 465 475 485
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 4,868 5,127 5,189 5,205
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1,035 1,018 1,061
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 9,009 8,699 8,916 9,086
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 3 3 3 3
Capital Surplus NA 9,846 9,801 9,766 9,692
Retained Earnings NA 10,385 10,015 9,902 9,742
Other Equity NA -183 -179 -171 -171
Treasury Stock NA 7,562 7,122 7,122 7,109
Total Shareholder's Equity NA 12,488 12,518 12,379 12,158
Total Liabilities & Shareholder's Equity NA 21,497 21,217 21,294 21,244
Total Common Equity 0 12,488 12,518 12,379 12,158
Shares Outstanding 205.40 208.90 208.90 208.90 208.50
Book Value Per Share 0.00 59.78 59.92 59.26 58.31